Annual Net Margin
-4527.66%
-4103.80%-968.20%
December 31, 2024
Summary
- As of March 13, 2025, TCRX annual net profit margin is -4527.66%, with the most recent change of -4103.80% (-968.20%) on December 31, 2024.
- During the last 3 years, TCRX annual net margin has fallen by -4048.17% (-844.27%).
- TCRX annual net margin is now -968.20% below its all-time high of -423.86%, reached on December 31, 2023.
Performance
TCRX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-5384.81%
-2535.72%-89.00%
December 31, 2024
Summary
- As of March 13, 2025, TCRX quarterly net profit margin is -5384.81%, with the most recent change of -2535.72% (-89.00%) on December 31, 2024.
- Over the past year, TCRX quarterly net margin has stayed the same.
- TCRX quarterly net margin is now -1879.78% below its all-time high of -271.99%, reached on December 31, 2023.
Performance
TCRX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
TCRX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -968.2% | 0.0% |
| 3 y3 years | -844.3% | -810.1% |
| 5 y5 years | - | -810.1% |
TCRX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -968.2% | at low | -1879.8% | +8.8% |
| 5 y | 5-year | -968.2% | at low | -1879.8% | +8.8% |
| alltime | all time | -968.2% | at low | -1879.8% | +8.8% |
TScan Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -4527.66%(+968.2%) | -5384.81%(+89.0%) |
| Sep 2024 | - | -2849.09%(-51.8%) |
| Jun 2024 | - | -5906.90%(+10.9%) |
| Mar 2024 | - | -5325.44%(+1858.0%) |
| Dec 2023 | -423.86%(-13.4%) | -271.99%(-54.0%) |
| Sep 2023 | - | -591.64%(-22.5%) |
| Jun 2023 | - | -763.82%(+130.3%) |
| Mar 2023 | - | -331.66%(-45.2%) |
| Dec 2022 | -489.26% | -604.94%(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -483.05%(+29.8%) |
| Jun 2022 | - | -372.21%(-30.4%) |
| Mar 2022 | - | -534.79%(+7.5%) |
| Dec 2021 | -479.49%(-80.1%) | -497.55%(-24.2%) |
| Sep 2021 | - | -656.68%(+75.2%) |
| Jun 2021 | - | -374.79%(-4.0%) |
| Mar 2021 | - | -390.33%(-60.3%) |
| Dec 2020 | -2408.02% | - |
| Dec 2020 | - | -982.01%(-60.3%) |
| Sep 2020 | - | -2472.41% |
FAQ
- What is TScan Therapeutics annual net profit margin?
- What is the all time high annual net margin for TScan Therapeutics?
- What is TScan Therapeutics annual net margin year-on-year change?
- What is TScan Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for TScan Therapeutics?
- What is TScan Therapeutics quarterly net margin year-on-year change?
What is TScan Therapeutics annual net profit margin?
The current annual net margin of TCRX is -4527.66%
What is the all time high annual net margin for TScan Therapeutics?
TScan Therapeutics all-time high annual net profit margin is -423.86%
What is TScan Therapeutics annual net margin year-on-year change?
Over the past year, TCRX annual net profit margin has changed by -4103.80% (-968.20%)
What is TScan Therapeutics quarterly net profit margin?
The current quarterly net margin of TCRX is -5384.81%
What is the all time high quarterly net margin for TScan Therapeutics?
TScan Therapeutics all-time high quarterly net profit margin is -271.99%
What is TScan Therapeutics quarterly net margin year-on-year change?
Over the past year, TCRX quarterly net profit margin has changed by 0.00% (0.00%)